Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-009818

Director sold 8,000 shares at an average $23.50 ($188,000)

  • Director acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
CHESS ROBERT Director 2020-02-12 Option exercise −8,000 $9.24 $73,920 284,973 D: show line 1 in the form
CHESS ROBERT Director 2020-02-12 Sale −4,401 $23.32 $102,631 280,572 D: show line 2 in the form
CHESS ROBERT Director 2020-02-12 Sale −3,599 $23.72 $85,368 276,973 D: show line 3 in the form
Open-market sales · 8,000 sh · avg $23.50 · $188,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
CHESS ROBERT Director 2020-02-12 Option exercise · Stock Option −8,000 32,000 D: show line 4 in the form
Loading xslF345X03/doc4.xml…